Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin

Long-term follow up study of MDMA-assisted psychotherapy for treatment of severe PTSD shows that 67 % of all participants no longer qualify as having PTSD one year after end of treatment

Psilocybin from yeast: First complete biosynthesis of potentially therapeutic psychedelic substance achieved

Psychedelic compound Ibogain patented for anti-addiction therapy